Drug profile · INN
fluocinolone acetonide
RETISERT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fluocinolone acetonide (RETISERT) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is fluocinolone acetonide?
fluocinolone acetonide (RETISERT) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for fluocinolone acetonide?
RETISERT is a marketed brand name for fluocinolone acetonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluocinolone acetonide?
fluocinolone acetonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.